Testing Lupatadine for dust mite allergies
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This study tests a new tablet (Lupatadine Fumarate) for people with nasal allergies caused by dust mites. It looks at how well the medicine works and what it does in the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have allergic rhinitis (nasal allergies) and a positive test for dust mite allergy
- You have not taken steroids, allergy medicines, or other drugs that affect the immune system in the last month
- You do not have other nose conditions like chronic sinusitis, nasal polyps, or a history of nose surgery
- You do not have other immune or allergic diseases, or serious heart, lung, or bleeding problems
- You are not pregnant and you do not smoke
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a dust-mite allergy extract (“allergy shots”) to see if it safely reduces symptoms from dust-mite–driven hay fever (rhinitis/rhinoconjunctivitis), and possibly asthma symptoms. If you qualify, it may help your immune system tolerate dust mites better over time.
This study looks at how a dust-mite allergy tablet (placed under the tongue) affects the tiny organisms in your nose. It may help doctors understand why some people respond better to the treatment.
This trial tests allergy drops placed under the tongue to treat allergic rhinitis caused by house dust mites. It aims to see if the drops can safely reduce symptoms like sneezing and stuffy nose.
This trial tests a spray placed under the tongue to treat allergic rhinitis caused by dust mites, pet dander, or mold. It looks at how the spray affects the bacteria in your nose and body.
This trial tests allergy shots for children with dust mite allergies causing rhinitis or asthma. It aims to see if guiding treatment with detailed allergy testing leads to better results.
This trial tests an under-the-tongue tablet for people with dust mite allergies causing moderate to severe nasal symptoms or mild-to-moderate asthma. The goal is to see if it improves symptoms and can replace or reduce the need for allergy medicines.
Hear when a new Allergic Rhinitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.